Search Results
Jul 21, 2026, 10:31 ET Acute Pain Market Forecast Signals Accelerated Growth at a CAGR of 12% During the Forecast Period (2026-2036), Driven by Novel Non-Opioid Therapies and Expanding Treatment Options | DelveInsight
investigational therapies include F14 (Arthritis Innovation/Medincell), OCS-01 (Oculis), NTM-001 (Neumentum), cebranopadol (TRN-228) (Tris Pharma), meloxicam (MR 107A 02) (Viatris), XG005 (Xgene Pharmaceutical), ATX101 (Allay Therapeutics), and others. These
More news about: DelveInsight Business Research, LLP
May 14, 2026, 19:01 ET Hormuz crisis shows clean energy is key to reducing the economic cost of fossil fuel dependence
disruption.If sustained, elevated fossil fuel prices could add $1-2trn in annual gross oil and gas expenditure. That is comparable to the annual clean energy investment gap of $1.5trn, between current investment levels of $2trn and the $3.5trn needed to build a net zero and more resilient energy system all
More news about: Energy Transitions Commission
May 14, 2026, 19:01 ET Hormuz crisis shows clean energy is key to reducing the economic cost of fossil fuel dependence
disruption.If sustained, elevated fossil fuel prices could add $1-2trn in annual gross oil and gas expenditure. That is comparable to the annual clean energy investment gap of $1.5trn, between current investment levels of $2trn and the $3.5trn needed to build a net zero and more resilient energy system all
More news about: Energy Transitions Commission
Apr 27, 2026, 09:00 ET EVS Launches AssureACH: Pre-Validate ACH Payments and Prevent Fraud
potential losses."Key features of AssureACH include:Real-time DDA account validationReal-time routing number (TRN) validationMulti-source database checksClosed account and stop payment detectionBad check and account history screeningAutomated
More news about: Electronic Verification Systems
Apr 09, 2026, 05:00 ET 2026 Kia CEO Investor Day: Kia to Drive Exponential Growth and Manufacturing Innovation by Expanding Its Full Electrified Vehicle Lineup and Strengthening Future Business Capabilities
2030 (KRW): Revenue 170 trn, OP 17 trn, OP Margin 10%5 Year Investment (2026~2030): KRW 49 trn (Future business Investment KRW 21 trn)2028
More news about: Kia Corporation
Feb 09, 2026, 09:07 ET New Study in JNCCN Unlocks Important Information About How to Treat Recurring Prostate Cancer
significant benefit compared to prostate bed radiotherapy alone. However, WPRT did significantly improve PFS for patients with local, visible disease (TrN0M0). For patients with nodal or distant metastatic disease visible on the scans, androgen deprivation therapy (ADT) was significantly associated with improved
More news about: National Comprehensive Cancer Network
Feb 04, 2026, 16:58 ET The Right Now Named PR Net's 2026 NextGen Lifestyle Agency of the Year
media landscape, The Right Now provides clients innovative and fully-integrated strategies that reach the consumer across all channels of communication. TRN seeks opportunities that expand beyond traditional offerings to include corporate social responsibility initiatives – a key driver in consumer purchase
More news about: The Right Now
Dec 15, 2025, 17:41 ET Piramal Pharma Solutions démontre son engagement envers l'excellence avec un taux de recommandation net exceptionnel
Piramal Pharma Solutions a récemment obtenu un taux de recommandation net (TRN) de 55, dépassant de loin les moyennes du secteur. Un prestataire tiers, DNV, a validé l'enquête et le TRN. Cette réalisation témoigne de l'engagement de l'entreprise en faveur d'une
More news about: Piramal Pharma Solutions
Nov 20, 2025, 04:00 ET Abacus Group Opens New Dubai Office to Drive Expansion Across the Middle East
the Middle East, Africa, and South Asia (MEASA), which comprises 77 countries with an approximate population of 3.8bn and an estimated GDP of USD 11.2trn. With a 20-year track record of facilitating trade and investment flows across the MEASA region, the Centre connects these fast-growing
More news about: Abacus Group LLC
Nov 20, 2025, 04:00 ET Abacus Group Opens New Dubai Office to Drive Expansion Across the Middle East
the Middle East, Africa, and South Asia (MEASA), which comprises 77 countries with an approximate population of 3.8bn and an estimated GDP of USD 11.2trn. With a 20-year track record of facilitating trade and investment flows across the MEASA region, the Centre connects these fast-growing
More news about: Abacus Group LLC
Oct 15, 2025, 19:35 ET 開創性國際雙語教育：香港包玉剛學校宣佈2026年9月開學
https://wetransfer.com/downloads/514df4a0b595363fff5afc78ab38d1ee20251015100630/db38624a579999ff4eab0f7c164e24e520251015100703/ada86b?trk=TRN_TDL_01&utm_campaign=TRN_TDL_01&utm_medium=email&utm_source=sendgrid
More news about: 包玉剛教育基金會
Oct 09, 2025, 08:29 ET Saudi Arabia's cultural economy in focus at high-profile Riyadh conference
Impact and Opportunities 2025', highlights the growing significance of the global cultural and creative industries, which contribute an estimated $2.3trn annually, or 3.1% of global GDP, and provide employment for around 30m people. In Saudi Arabia, the cultural sector's GDP contribution
More news about: Oxford Business Group
Oct 09, 2025, 08:19 ET Saudi Arabia's cultural economy in focus at high-profile Riyadh conference
Impact and Opportunities 2025', highlights the growing significance of the global cultural and creative industries, which contribute an estimated $2.3trn annually, or 3.1% of global GDP, and provide employment for around 30m people. In Saudi Arabia, the cultural sector's GDP contribution
More news about: Oxford Business Group
Sep 24, 2025, 17:31 ET Moderate-to-Severe Acute Pain Market Anticipates Impressive Growth Trajectory at a CAGR of 14% During the Study Period (2020-2034) | DelveInsight
and late-stage development products such as Arthritis Innovation/Medincell (F14), Oculis (OCS-01), Neumentum (NTM-001), Tris Pharma (cebranopadol [TRN-228]), Viatris (meloxicam [MR 107A 02]), Xgene Pharmaceutical (XG005), Allay Therapeutics (ATX101), and others, which hold significant potential for improving
More news about: DelveInsight Business Research, LLP